RETRACTED ARTICLE: microRNA-15b-5p encapsulated by M2 macrophage-derived extracellular vesicles promotes gastric cancer metastasis by targeting BRMS1 and suppressing DAPK1 transcription

Abstract

Background Extracellular vesicles (EVs) derived from tumor-associated macrophages are implicated in the progression and metastasis of gastric cancer (GC) via the transfer of molecular cargo RNAs. We aimed to decipher the impact of microRNA (miR)-15b-5p transferred by M2 macrophage-derived EVs in the metastasis of GC. Methods Expression of miR-15b-5p was assessed and the downstream genes of miR-15b-5p were analyzed. GC cells were subjected to gain- and loss-of function experiments for miR-15b-5p, BRMS1, and DAPK1. M2 macrophage-derived EVs were extracted, identified, and subjected to co-culture with GC cells and their biological behaviors were analyzed. A lung metastasis model in nude mice was established to determine the effects of miR-15b-5p on tumor metastasis in vivo. Results miR-15b-5p was upregulated in GC tissues and cells as well as in M2 macrophage-derived EVs. miR-15b-5p promoted the proliferative and invasive potentials, and epithelial-mesenchymal transition (EMT) of GC cells. M2 macrophage-derived EVs could transfer miR-15b-5p into GC cells where it targeted BRMS1 by binding to its 3’UTR. BRMS1 was enriched in the DAPK1 promoter region and promoted its transcription, thereby arresting the proliferative and invasive potentials, and EMT of GC cells. In vivo experiments demonstrated that orthotopic implantation of miR-15b-5p overexpressing GC cells in nude mice displayed led to enhanced tumor metastasis by inhibiting the BRMS1/DAPK1 axis. Conclusions Overall, miR-15b-5p delivered by M2 macrophage-derived EVs constitutes a molecular mechanism implicated in the metastasis of GC, and may thus be considered as a novel therapeutic target for its treatment.

The CAR macrophage cells, a novel generation of chimeric antigen-based approach against solid tumors

“…This structure could target M2-like macrophages appropriately and deplete them by functional remodeling of TME, like reducing the immunosuppressive function, elevating immune improvement cytokines, and intratumoral perfusion in-vivo and in-vitro [ 269 ]. In another approach, uses of miRs can restrain the M2-like cells such as miR-770, miR-183-5p, and miR-15b-5p [ 270 , 271 ]. For instance, tumor-derived exosomal MiR-770 with downregulation of MAP3K1 can suppress the M2-like cells and inhibit the invasion in NSCLC cancers [ 272 ].…”

Tumor microenvironment-mediated immune tolerance in development and treatment of gastric cancer

“…LncRNA CRNDE ( 108 ), miR-588 ( 109 ), miR-21 ( 110 ) in M2-polarized TAM-derived exosomes can enhance the resistance of GC cells to cisplatin, while miR-223 enhances GC cell resistance to doxorubicin ( 111 ), Meanwhile, miR-487a, miR-130b-3p can promote the progression of GC ( 112 , 113 ). M2 macrophage-derived miR-15b-5p can promote GC metastasis through the BRMS1/DAPK1 axis ( 114 ). M1-polarized TAM-derived exosomes can down-regulate the expression of PD-L1 in gastric cancer cells through miR-16-5p and activate T cell immunity ( 115 ).…”

Adipose Tissue-Derived Extracellular Vesicles Contribute to Phenotypic Plasticity of Prostate Cancer Cells

“…In summary, EVs have been shown to contain protein and nucleic acid cargo that participate in intercellular signaling and may promote tumor progression and establishment of the pre-metastatic niche [ 28 ]. EV-contained miRNA and protein have been found to promote invasion and metastasis in multiple cancer types [ 29 , 30 , 31 , 32 , 33 , 34 ].…”